NCT06028685View on ClinicalTrials.gov

Acupoint Stimulation Improves Fatigue and Sleep Quality in Patients With Postdialysis

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

February 21, 2023

Conditions
Hemodialysis
Interventions
DEVICE

Acupoint stimulation

The experimental group will receive low-level laser stimulation on seven acupoints, including Shenmen (HT7), Neiguan (PC6), Hegu (LI4), Zusanli (ST36), Yanglingquan (GB34), Sanyinjiao (SP6), and Taixi (KI3). The stimulation will be administered three times per week for a duration of six weeks.

DEVICE

Acupoint stimulation(placebo)

The control group will receive sham low-level laser stimulation on seven acupoints, including Shenmen (HT7), Neiguan (PC6), Hegu (LI4), Zusanli (ST36), Yanglingquan (GB34), Sanyinjiao (SP6), and Taixi (KI3), without emitting laser beams.The stimulation will be administered three times per week for a duration of six weeks.

Trial Locations (1)

11217

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV